【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: An overview of dyslipidemia
PART 06: Pipeline analysis
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Market segmentation by drug class
• Statins
• Cholesterol absorption inhibitors
• Dyslipidemia injectables
• Others
PART 09: Geographical segmentation
• Dyslipidemia drugs market in Americas
• Dyslipidemia drugs market in EMEA
• Dyslipidemia drugs market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 12: Market trends
• Increasing use of statins
• Combination therapies
• Increased uptake of OTC drugs
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• Aegerion Pharmaceuticals
• AstraZeneca
• Merck
• Pfizer
• Sanofi
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
[List of Exhibits]
Exhibit 01: Key customer segments
Exhibit 02: Overview of phase III pipeline molecules in global dyslipidemia drugs market
Exhibit 03: Pipeline analysis
Exhibit 04: Global dyslipidemia drugs market snapshot 2016
Exhibit 05: Global dyslipidemia drugs market 2016-2021 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global dyslipidemia drugs market by drug class
Exhibit 08: Global statin market 2016-2021 ($ millions)
Exhibit 09: Global cholesterol absorption inhibitors market 2016-2021 ($ millions)
Exhibit 10: Global dyslipidemia injectables market 2016-2021 ($ millions)
Exhibit 11: Global dyslipidemia drugs market by geography 2016 and 2021
Exhibit 12: Dyslipidemia drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 13: Market scenario in Americas
Exhibit 14: Dyslipidemia drugs market in Americas 2016-2021 ($ millions)
Exhibit 15: Market scenario in EMEA
Exhibit 16: Dyslipidemia drugs market in the EMEA 2016-2021 ($ millions)
Exhibit 17: Market scenario in APAC
Exhibit 18: Dyslipidemia drugs market in APAC 2016-2021 ($ millions)
Exhibit 19: Population aged 60 years and over: World and developed and developing regions (millions)
Exhibit 20: Impact of drivers
Exhibit 21: Impact of challenges
Exhibit 22: Competitive structure analysis of global dyslipidemia drugs market 2016
Exhibit 23: Competitive analysis of global dyslipidemia drugs market 2016
Exhibit 24: Market penetration of various players in global dyslipidemia drugs market 2016
Exhibit 25: Aegerion Pharmaceuticals: Key highlights
Exhibit 26: Aegerion Pharmaceuticals: Strength assessment
Exhibit 27: Aegerion Pharmaceuticals: Strategy assessment
Exhibit 28: Aegerion Pharmaceuticals: Opportunity assessment
Exhibit 29: AstraZeneca: Key highlights
Exhibit 30: AstraZeneca: Strength assessment
Exhibit 31: AstraZeneca: Strategy assessment
Exhibit 32: AstraZeneca: Opportunity assessment
Exhibit 33: Merck: Key highlights
Exhibit 34: Merck: Strength assessment
Exhibit 35: Merck: Strategy assessment
Exhibit 36: Merck: Opportunity assessment
Exhibit 37: Pfizer: Key highlights
Exhibit 38: Pfizer: Strength assessment
Exhibit 39: Pfizer: Strategy assessment
Exhibit 40: Pfizer: Opportunity assessment
Exhibit 41: Sanofi: Key highlights
Exhibit 42: Sanofi: Strength assessment
Exhibit 43: Sanofi: Strategy assessment
Exhibit 44: Sanofi: Opportunity assessment
【レポート販売概要】
■ タイトル：脂質異常症治療薬の世界市場2017-2021■ 英文：Global Dyslipidemia Drugs Market 2017-2021
■ 発行日：2017年3月15日
■ 調査会社：Technavio
■ 商品コード：IRTNTR12273
■ 調査対象地域：グローバル
- 先進複合材料の世界市場：炭素繊維複合材、S-ガラス複合材、アラミド繊維複合材The advanced composites market size of end products in terms of value was $16.3 billion in 2014 and expected to grow at a CAGR of 7.2% between 2015 and 2020. North America held the largest share by volume in advanced composites market in 2014. Major growth in the North America region is expected from the growing aerospace & defense application industry. The advanced composites market in Asia-Pacif …
- ESP（電動水中ポンプ）の世界市場：Borewell水中ポンプ、Openwell水中ポンプAbout ESP A submersible pump is a type of artificial lift system (ALS), which is completely submerged in the fluid to be pumped. It is also referred to as ESP. The basic operation of ESPs is based on the principle that they push, rather than pull, the fluid being dealt with. They are usually featured as single stage or multistage. Every stage of a submersible pump involves a motor, enclosed in a c …
- 外科器具追跡システムの世界市場：RFID、バーコードThe global surgical instrument tracking systems market is expected to reach USD 204.8 Million by 2021 from USD 92.2 Million in 2016, growing at a CAGR of 17.3% from 2016 to 2021. Factors such as the UDI regulations by FDA, rising need for inventory management and better patient care, and the need to maximize revenues through operational efficacy are expected to drive market growth in the coming ye …
- ICT調達動向：エネルギー産業部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which energy companies select their ICT providers as well as the roles which have influence while making ICT purchasing decisions. What is the current market landscape and what is changing? As energy companies face several legal and regulatory compliance issues, the sector is witnessing a slow adoption of cloud computing. However, hosted dep …
- 呼気検査機の世界市場2016-2020About Breath Analyzers Breath analyzers are usually handheld devices that can accurately detect the BAC of a person with the help of his or her breath sample. The device uses one of these three technologies to detect the BAC of a person –– infrared, semiconductor, and fuel cell technology. Breath analyzers are commonly used by law enforcement agencies to ensure that people do not drive under the i …
- 市場インサイト：消費者決済およびリテールバンクにおけるセキュリティTimetric’s 'Insight Report: Security in Consumer Payments and Retail Banks' provides insights into security threats to consumer payments, and the approaches taken by retail banks to counter them. It also: • Analyzes the methods of major attacks on payment systems. • Covers key challenges faced by banks in defending consumer payments. • Explores initiatives taken by banks to secure payment infrastr …
- スチレン系ブロック共重合体（SBC）及び誘導体の世界市場2016-2020：SBS、SIS、SEBS、HSBCStyrenic block copolymers, commonly known as SBCs, belong to the family of thermoplastic elastomers. These polymers are consumed in bulk compared with other thermoplastic elastomers and exhibit properties similar to rubber, though they are processed as thermoplastics. They are added in additives and other high-performance polymeric compounds for the formulation of many products. Technavio’s analys …
- 360度カメラの世界市場2016-2020About 360-Degree Camera 360-degree cameras are considered to be revolutionary VR products. A 360-degree camera records a video simultaneously from all angles of a scene. Spherical view originated from street view. It converts a 360-degree view into a landscape image. 360-degree cameras were primarily used for mapping. Over the years, 360-degree cameras have found applications in various domains. 3 …
- クラウドPLM（製品ライフサイクル管理）の世界市場2016-2020About Product Lifecycle Management Many manufacturing companies require PLM software, as it helps deal with different functional levels of an organization such as design engineering, product designing, and manufacturing. The need for managing a product from the concept to servitization has led to the emergence of PLM software and services. The rising product complexity and increase in product port …
- 世界のスマートシティ市場Summary 'Smart Cities: A Challenging but Attractive Opportunity for Network Operators,' a Research Report by Pyramid Research, analyzes the smart city proposition for network operators worldwide and how they are addressing the opportunity. The report discusses the urbanization trends worldwide and provides an in-depth analysis of elements of smart city services, the stakeholders in smart city proj …
- 医療機器業界のM&A及び投資動向（月別）：September 2013Medical Equipment Monthly Deals Analysis: September 2013 - M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: September 2013 - M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt …
- フォトニック集積回路（IC）の世界市場分析：コンポーネント別（レーザー、MUX / DEMUX、光増幅器、変調器、減衰器、および検出器）、集積別（モノリシック、ハイブリッド、およびモジュール）、原材料別（インジウム・リン、シリコン・オン・シリコン、シリコン、ガリウムヒ素その他）、用途別（光通信、センシング、バイオフォトニクス、光信号処理）、セグメント予測The photonic IC market is expected to reach USD 3.54 billion by 2024 according to a new report by Grand View Research, Inc. Photonic IC is an integrated circuit that uses optical wavelength as an information signal and provides multiple integrated photonic functions. Photonic IC, as such, is similar to an electronic IC and can be a viable replacement for it as well as for the copper-based wired tr …
- Belviq（肥満治療薬）：市場予測及び分析（～2022）Belviq (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molec …
- コネクテッドカーのインド市場Increase in demand for smart mobility is expected to fuel the connected car market in IndiaThe India connected car market is estimated to be USD 9.8 billion in 2018 and is projected to reach USD 32.5 billion by 2025, at a CAGR of 22.2% from 2019` to 2025. The key factor driving the growth of the market is the increase in number of connected features in economy vehicles by OEMs. Additionally, an in …
- 持続的腎代替療法装置の世界市場2018-2022About this market The incidence of AKIs in ICU patients is increasing, and severe cases of AKI are mostly treated through renal replacement therapy (RRT). CRRT is the most preferred therapy in ICU patients suffering from AKI due to their hemodynamic instability. Acute renal failures are common and can lead to serious complications in severely ill patients. The use of renal replacement therapy has …
